The importance of organized lung cancer screening: A personal point of view

Lung cancer is the leading cause of oncology mortality worldwide. In the last two decades, low dose CT lung cancer screening has established itself as the method of choice in high-risk populations. Many challenges, however, still arise – what are the best methods to reach those who benefit from screening? The question of incidental and additional findings is more than just a diagnostic one – it is also a medico-legal one. The definition of who is seen as high risk is also evolving, with a special focus on never-smokers. Finally, LCS programs were mainly developed in high income countries. Currently, it is unknown whether these data can be transferred and to what extent to low- and middle income countries. This paper will demonstrate the current dilemmas in lung cancer screening – from a purely personal point of view.